Postdoctoral Positions in Antibody Engineering for the Development of Cancer Therapeutics
Postdoctoral positions are
available in the laboratory of Drs. E. Sally Ward and Raimund J. Ober at
UT Southwestern Medical Center at Dallas. These positions are supported
by recently acquired funds from the
Cancer Prevention and Research Institute of Texas (
www.cprit.state.tx.us).
Post-doctoral appointees will work on projects involving the use of
antibody engineering approaches to develop therapeutics for cancer that
target growth factor receptors and exposed phosphatidylserine (PS).
These studies will use a combination of
in vitro and
in vivo studies in mice to analyze therapeutic efficacy.
These projects have direct relevance to the rapidly expanding use of antibodies in the biopharma industry.
For more information on the research carried out in the laboratory see www4.utsouthwestern.edu/wardlab or publications such as J. Immunol., 187, 1015, 2011; Proc. Natl. Acad. Sci. USA, 106, 2788-2793, 2009; Traffic, 10, 600-614, 2009; Biophys J., 95, 6025-6043, 2008; Proc. Natl. Acad. Sci. USA, 104, 5889-5894, 2007; Proc. Natl. Acad. Sci. USA, 103, 4457-4462, 2006; Nature Biotechnol., 23, 1283-1288, 2005; Proc. Natl. Acad. Sci. USA, 101, 11076-11081, 2004; J. Immunol., 172, 2021-2029, 2004.
Highly motivated individuals with a Ph.D. in any
biological area, (bio)engineering, biotechnology, or chemistry should
apply. Relevant experience is desirable but is not essential.
UT Southwestern is an Equal Opportunity, Affirmative Action Employer.